Skip to main content
. 2019 Dec 15;22(3):253–262. doi: 10.22074/cellj.2020.6728

Fig 1.

Fig 1

Molecular target of sorafenib and arsenic trioxide (ATO). A. Sorafenib is known as a multikinase inhibitor which acts through suppressing Ser/ Thr kinase Raf that is known to have important roles in tumor cell signaling and proliferation and B. ATO as a single agent, targets various cellular functions through affecting multiple molecular factors. ATO activates both autophagy and apoptosis.